These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11728609)

  • 21. A pilot study of impulsivity and compulsivity in pathological gambling.
    Blanco C; Potenza MN; Kim SW; Ibáñez A; Zaninelli R; Saiz-Ruiz J; Grant JE
    Psychiatry Res; 2009 May; 167(1-2):161-8. PubMed ID: 19339053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients.
    Kamijima K; Murasaki M; Asai M; Higuchi T; Nakajima T; Taga C; Matsunaga H
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):427-33. PubMed ID: 15298657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of geriatric patients seeking medication treatment for pathologic gambling disorder.
    Grant JE; Kim SW; Brown E
    J Geriatr Psychiatry Neurol; 2001; 14(3):125-9. PubMed ID: 11563435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetine.
    Ninan PT
    Psychopharmacol Bull; 2003; 37 Suppl 1():89-96. PubMed ID: 14566204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body dysmorphic disorder, pathological gambling, and sexual compulsions.
    Hollander E; Wong CM
    J Clin Psychiatry; 1995; 56 Suppl 4():7-12; discussion 13. PubMed ID: 7713866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of personality disorders in children and adolescents with obsessive-compulsive disorder. A 6- to 22-year follow-up study.
    Thomsen PH; Mikkelsen HU
    Acta Psychiatr Scand; 1993 Jun; 87(6):456-62. PubMed ID: 8356899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
    Geller DA; Biederman J; Stewart SE; Mullin B; Farrell C; Wagner KD; Emslie G; Carpenter D
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S19-29. PubMed ID: 12880497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.
    Denys D; Van Nieuwerburgh F; Deforce D; Westenberg HG
    J Clin Psychiatry; 2007 May; 68(5):747-53. PubMed ID: 17503984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paroxetine treatment of compulsive hoarding.
    Saxena S; Brody AL; Maidment KM; Baxter LR
    J Psychiatr Res; 2007 Sep; 41(6):481-7. PubMed ID: 16790250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
    Denys D; van der Wee N; van Megen HJ; Westenberg HG
    J Clin Psychopharmacol; 2003 Dec; 23(6):568-75. PubMed ID: 14624187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbidity between obsessive-compulsive disorder (OCD) and personality disorders.
    Bejerot S; Ekselius L; von Knorring L
    Acta Psychiatr Scand; 1998 Jun; 97(6):398-402. PubMed ID: 9669509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low novelty-seeking differentiates obsessive-compulsive disorder from major depression.
    Kusunoki K; Sato T; Taga C; Yoshida T; Komori K; Narita T; Hirano S; Iwata N; Ozaki N
    Acta Psychiatr Scand; 2000 May; 101(5):403-5. PubMed ID: 10823301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.
    Humble MB; Uvnäs-Moberg K; Engström I; Bejerot S
    BMC Psychiatry; 2013 Dec; 13():344. PubMed ID: 24359174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Tridimensional Personality Questionnaire in depression: state versus trait issues.
    Chien AJ; Dunner DL
    J Psychiatr Res; 1996; 30(1):21-7. PubMed ID: 8736463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
    McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
    Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hoarding in obsessive compulsive disorder: results from a case-control study.
    Samuels J; Bienvenu OJ; Riddle MA; Cullen BA; Grados MA; Liang KY; Hoehn-Saric R; Nestadt G
    Behav Res Ther; 2002 May; 40(5):517-28. PubMed ID: 12043707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
    Costa DLC; Diniz JB; Requena G; Joaquim MA; Pittenger C; Bloch MH; Miguel EC; Shavitt RG
    J Clin Psychiatry; 2017 Jul; 78(7):e766-e773. PubMed ID: 28617566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compulsive behaviors and obsessive-compulsive disorder (OCD): lack of a relationship between OCD, eating disorders, and gambling.
    Black DW; Goldstein RB; Noyes R; Blum N
    Compr Psychiatry; 1994; 35(2):145-8. PubMed ID: 8187479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
    Landeros-Weisenberger A; Bloch MH; Kelmendi B; Wegner R; Nudel J; Dombrowski P; Pittenger C; Krystal JH; Goodman WK; Leckman JF; Coric V
    J Affect Disord; 2010 Feb; 121(1-2):175-9. PubMed ID: 19577308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.